Daily Stock List
Sigma Labs, Inc. (SGLB)
PennyStocks24, Top Stock Picks, Penny Stock Rumble, and Wall Street Corner reported on Sigma Labs, Inc. (SGLB), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQB listed Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and research and development (R&D) solutions. Through their wholly-owned subsidiary, B6 Sigma, Inc., Sigma Labs develops and engineers advanced, real-time, non-destructive quality inspection systems for commercial firms globally looking for productive solutions for 3D metal printing and other advanced manufacturing technologies. Its B6 Sigma subsidiary brings new materials and process technologies to market for advanced applications in aerospace, defense, energy, and other areas. Sigma Labs has its headquarters in Santa Fe, New Mexico.
Sigma Labs concentrates on bringing novel and advanced materials and manufacturing technologies out of the nation's top National Labs and into the market to serve the aerospace, defense, biomedical, power generation, and general industrial sectors. The Company consists of top scientists and engineers from Los Alamos National Laboratory. Sigma Labs has current contracts with Federal Government and private industry clients. These contracts are to develop technologies from their conception through the design, building, and testing of prototype systems via integrating sensing, software, materials, and manufacturing technology risk-reduction solutions.
Its methodology will be to commercialize technologies through partnerships, joint development, and licensing with other firms. These technologies include the Company’s unique PrintRite3D® technology. This technology will allow metals parts to be built by 3D printing or additive manufacturing with less flaws and better properties.
Sigma Labs' other wholly-owned subsidiary is Sumner & Lawrence. This subsidiary provides high-level scientific consultants to Federal government clients looking for productive solutions for developing and strategic development technologies. Sumner & Lawrence offers affordable consulting services to commercial clients that are founded on sound science, an unprejudiced perspective, and multi-disciplined capabilities.
In April, Sigma Labs announced it signed a Technology Cooperation Agreement with Materialise NV of Leuven, Belgium. The agreement sets forth the parties' intention to collaborate technically and commercially in the integration, production, and marketing of PrintRite3D® software-related products for metal-based additive manufacturing.
Sigma Labs, Inc. (SGLB), closed Tuesday's trading session at $0.155, up 3.40%, on 4,045,895 volume with 373 trades. The average volume for the last 60 days is 3,357,647 and the stock's 52-week low/high is $0.0222/$0.276.
OncoSec Medical, Inc. (ONCS)
Streetwise Reports, PennyStocks24, SmallCap Network, SmallCap Fortunes, and Stock Analyzer reported earlier on OncoSec Medical, Inc. (ONCS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
A bio-pharmaceutical company, OncoSec Medical, Inc. is developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors. Its mission is to pioneer and refine new electroporation technologies that endeavor to benefit patients and improve the quality of life for those whose skin cancers cannot be treated effectively with conventional treatment approaches. OncoSec Medical lists on the OTC Markets’ OTCQB. The Company has its corporate head office in San Diego, California.
OncoSec’s central technology leverages a proprietary electroporation platform to enhance the local delivery and uptake of IL-12 and other DNA-based immunocytokines. Clinical studies of ImmunoPulse have demonstrated positive safety and preliminary efficacy in the treatment of different skin cancers, and its potential to initiate a systemic immune response without the toxicities associated with many other systemic treatments. The Company’s clinical programs include three Phase II clinical trials for ImmunoPulse targeting metastatic melanoma, Merkel cell carcinoma, and cutaneous T-cell lymphoma.
In addition, OncoSec has its NeoPulse. It uses the OMS system to destroy cancer cells using less harmful doses of bleomycin, a highly effective but also highly toxic anti-cancer drug. Clinical trial results suggest NeoPulse may enhance local activity of the anti-cancer drug bleomycin. This is while minimizing systemic side effects. Pre-clinical and clinical data from Phase 1 through Phase 4 clinical trials demonstrate NeoPulse technology holds promise as a treatment for solid tumors (including melanoma, basal cell carcinoma, squamous cell carcinoma, and liver and pancreatic cancers) with observable cancer cell destruction.
ImmunoPulse and NeoPulse therapies address an unmet medical need. They represent a potential solution for less invasive and less expensive therapies that can lessen detrimental effects resulting from presently available cancer treatments, including surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.
Yesterday, OncoSec Medical presented preliminary experimental findings demonstrating that electroporation with DNA-based IL-12 in mice can lead to systemic anti-tumor immune responses in distant untreated lesions. These data are consistent with the previously reported findings in melanoma patients treated in the Phase 2 OMSI100 study (December 2013).
OncoSec Medical, Inc. (ONCS), closed Tuesday's trading session at $0.77, down 3.14%, on 896,971 volume with 273 trades. The average volume for the last 60 days is 3,439,176 and the stock's 52-week low/high is $0.226/$0.97.
Valuesetters, Inc. (VSTR)
Real Pennies reported previously on Valuesetters, Inc. (VSTR), and today we highlight the Company, here at the QualityStocks Daily Newsletter
Founded in 2010, Valuesetters, Inc. is an Internet-based company that looks for free subscribers and revenue-generating subscribers. The Company’s intention is to attract global subscribers through providing consumers with digital games, videos, music, voice, texting, and other cloud-based applications. Valuesetters’ belief is that Internet operations, customer sign-ups, and game playing should occur without human intervention so that it can scale quickly in the event the number of subscribers of the game begins to rapidly grow on a viral basis. Valuesetters is based in White Plains, New York. The Company lists on the OTC Markets’ OTCQB.
As an example, Valuesetters allows subscribers to play games of chess for free and not receive rankings. It charges a fee to play the game against advanced players and to receive a ranking. The Company operates on an automated basis. Valuesetters relies considerably on the programs it purchased. This includes the assets of NetGames.com. The Company’s intention is to acquire other Internet-based games and programs that can generate revenue with a minimum of personnel.
The games on Valuesetters website employ software technology that provides user-friendly graphics, and allows real time interactivity with a competitor. The Company’s one operational website is www.chess.net. This site allows a person to play chess online, without typing any words, unless the individual desires to use the portal’s chat feature. Users have the option of loading and playing games via their web browser with no downloading. A user may download its chess software to play rated games and enter tournaments. An individual need not open an account to browse the website or play pick-up games. However, to enter chess tournaments and develop a track record that allows a person to be ranked against other players, a person must purchase a monthly, quarterly or annual membership.
Valuesetters’ plan is to develop other interactive Internet-based games. These include games, which are designed for smart phone users. The Company has entered into an agreement to license and distribute songs, music videos and games over the Internet, using a platform that has been built by an independent party. In the fourth quarter of fiscal 2014, Valuesetters commenced reselling a mobile voice over Internet Protocol (VoIP) application to smartphone users.
At the end of March 2014, Valuesetters announced that it signed an agreement with Pervasip Corp. (PVSP) to develop and operate its V-Star calling app on the Google Play store. The integrated products will allow V-Star to launch a full-featured mobile communications service.
Valuesetters, Inc. (VSTR), closed Tuesday's trading session at $0.041, up 41.38%, on 8,515,157 volume with 303 trades. The average volume for the last 60 days is 292,158 and the stock's 52-week low/high is $0.0009/$0.035.
Liquidmetal Technologies, Inc. (LQMT)
Jason Bond, PennyStocks24, and Greenbackers reported on Liquidmetal Technologies, Inc. (LQMT), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Listed on the OTC BB, Liquidmetal Technologies, Inc. is the leading developer of amorphous alloys and composites, which use the performance advantages that amorphous alloy technology offers. Amorphous alloys are unique materials distinguished by their ability to retain a random structure when they solidify. This is in contrast to the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal Technologies is based in Rancho Santa Margarita, California.
The Company is the first business to produce amorphous alloys in commercially viable bulk form. This is permitting key improvements in products across a wide spectrum of industries. Its class of patented alloys and processes form the foundation of high performance materials used in a wide variety of medical, military, consumer, and industrial, and sporting goods products.
Liquidmetal Technologies controls the intellectual property (IP) rights with more than 50 U.S. patents. The Company’s alloys are, in several cases, stronger, harder, more elastic, and more wear and corrosion resistant than generally used high-performance alloys. Liquidmetal has two to three times the strength of titanium and stainless steel. They undergo processing similar to plastics on the Company's proprietary Liquidmetal molding machines.
Liquidmetal is processed and solidified in a vitreous or amorphous state (frozen liquid). Liquidmetal Technologies’ "bulk" amorphous alloys possess advantages typically associated with plastics. This includes the ability to undergo molding into precision, complex, and highly finished products.
In March, Liquidmetal Technologies announced that it hired Mr. Paul Hauck as VP of World-Wide Sales and Support. Mr. Hauck’s background includes a primary focus on Metal Injection Molding (MIM). He has spent his entire career in contract manufacturing businesses that produce precision metal components using various metallurgy technologies.
Last week, Liquidmetal Technologies announced that it would hold a conference call on Thursday, May 8th at 4:30 p.m. Eastern time to discuss results for the first quarter ended March 31, 2014. Financial results will be issued in a press release after the close of market on the same day. The Company’s president and Chief Executive Officer, Mr. Tom Steipp, and Chief Financial Officer, Mr. Tony Chung will host the presentation, followed by a question and answer period.
Liquidmetal Technologies, Inc. (LQMT), closed Tuesday's trading session at $0.191, down 9.99%, on 3,292,968 volume with 370 trades. The average volume for the last 60 days is 5,243,540 and the stock's 52-week low/high is $0.0521/$0.408.
The Digital Development Group Corp. (DIDG)
PennyStocks24 and Pennybuster reported recently on The Digital Development Group Corp. (DIDG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Based in Hollywood, California, The Digital Development Group Corp. operates in the entertainment industry. This past March, it changed its operating name to "The Movie & Music Network." An online content provider, previously known as DigiDev TV, it has had considerable subscriber growth over the last two quarters (previous to March 2014). Since the launch of the Movie & Music Network website and Roku application March 6, 2014, it has experienced an approximate 10 percent increase in subscribers and approximately 15,000 downloads of its application. The simultaneous launch of four new channels brings the total to 16 channels offered by The Movie & Music Network. Company plans are for adding a minimum of ten channels per quarter.
The Company consists of a group of highly experienced technology entrepreneurs and entertainment industry professionals. It is targeting the rapidly expanding world of “OTT” television (Over-The-Top Content (OTT)). OTT is the online delivery of video and audio to consumer devices without the Internet Service Provider (ISP) being involved in the control or distribution of the content itself.
The Digital Development Group is creating a unique and engaging experience in the delivery of movie, games, applications, and niche content to millions of connected devices and users worldwide. It provides a seamless, scalable, and integrated back-end technological solution. This gives content owners distribution capability across many platforms employing existing Internet Protocol (IP) services, providing increased monetization opportunities and greater control over distribution. It licenses content from owners and converts it into multiple formats. In this fashion, the same content can be consumed through devices as varied as a home theater or a smartphone.
The principal features of its new standard of OTT delivery, management, and monetization are that it publishes to multiple sources - (OTT) and more. Furthermore, it has easy usability with rich applications and video assets; user-driven engagement of platform content; interactive product placement and “click to buy” in-video applications; advertisement/advertainment solutions, and an agnostic billing platform.
The Movie & Music Network (DIDG) reported a 66 percent increase in subscriber growth for March over February, and a 66 percent growth in revenue for the same period. For the quarter ending March 31, 2014, this represents revenue growth of 32 percent and a 35 percent increase in subscriber growth over the previous quarter.
Today, The Digital Development Group, operating as The Movie & Music Network, announced the upcoming launch, in conjunction with Moxe Productions, of a pioneering network devoted entirely to the cannabis lifestyle.
Chairman, Mr. Martin W. Greenwald, said, "We've spent the last several months on the development of this internet network to cover all aspects of the cannabis/marijuana industry. We're now ready to launch our first channel on Independence Day, July 4, 2014."
The Digital Development Group Corp. (DIDG), closed Tuesday's trading session at $0.0375, up 1.35%, on 1,015,596 volume with 55 trades. The average volume for the last 60 days is 1,409,964 and the stock's 52-week low/high is $0.0055/$0.099.
Victory Energy Corp. (VYEY)
The QualityStocks Daily Newsletter would like to spotlight Victory Energy Corp. (VYEY). Today, Victory Energy Corp. closed trading at $0.35, up 14.75%, on 100 volume with 1 trades. The stock’s average daily volume over the past 60 days is 6,200, and its 52-week low/high is $0.0136/$0.51.
Victory Energy Corp. today announced that it has successfully completed the Company's fourth well on its Permian Basin Lightnin Prospect, the Cotter 6 #2, located in Glasscock County Texas. The well was drilled and completed in March, 2014 and has averaged daily gross flow rates of 121 BOE during the month of April, representing a net 18 BOEPD to the company's interest and a 41% growth in daily production since March 31, 2014.
Victory Energy Corp. (VYEY) is an independent, growth-oriented oil and gas company focused on growing proved reserves and cash-flow via the continued development of existing properties and the acquisition of new resource properties, primary located in the prolific Permian Basin of Texas and southeast New Mexico. The Company will source new capital to facilitate this growth by continuing to utilize an established pipeline of investors available through Aurora Energy Partners and additional third-party sources. The company is committed to creating long-term shareholder value by increasing oil reserves, lowering costs, boosting production volumes, and prudently managing the capital on its balance sheet.
The company is geographically focused onshore, with a primary emphasis on the Permian Basin of Texas and southeast New Mexico. Victory strategically utilizes both internal capabilities and strategic industry relationships to acquire non-operated working interest positions in low-to-moderate risk oil and gas prospects. Its focus is on oil or liquid-rich gas projects within longer-life reservoirs that offer competitive finding and development (F&D) costs per barrel of oil equivalent (BOE).
Victory’s carefully assembled management team has more than 120 years of direct and relevant oil and gas experience. The company also utilizes a team of third-party professionals on an as-needed basis. This team includes geologists for property evaluation and assessment and reservoir engineering resources for the analysis of current and new properties. Reserve reporting is performed by a third-party engineer located in Midland, Texas. Each independent operator utilized by the company also has their own array of experts.
As it executes its strategy, Victory will be targeting investment in larger working interest projects (10%-25% that are weighted toward oil and high-BTU natural gas. This approach of increasing economic interest should allow for improved returns through cost efficiencies derived from economies of scale. Lower expenses and additional capital will give the company added flexibility to invest in the development of its current proven undeveloped, possible, and probable reserves, while also allowing for additional oil and gas prospects and improved working interest positions. Disclaimer
Victory Energy Corp. Company Blog
Victory Energy Corp. News:
Victory Energy Successfully Completes Fourth Well in Its Permian Lightnin Prospect
Victory Energy Corporation Engages MZ Group for Investor Relations
Victory Energy Engages Euro Pacific Capital
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.006, even for the day. The stock’s average daily volume over the past 60 days is 278,273, and its 52-week low/high is $0.004/$0.031.
Consorteum Holdings, Inc. today announced that its wholly owned subsidiary, ThreeFiftyNine Inc., has entered into a binding agreement with XpertX Inc. to develop a mobile offering for XpertX's existing keno gaming service. This agreement follows on the heels of ThreeFiftyNine's new partner program announcement and with proof-of-concept now validated, this new mobile offering that is designed to deliver a state-of-the-art mobile Keno solution to virtually any mobile device, regardless of operating system, is soon to drop.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Enters Mobile Application Development and Business Agreement With XpertX, Inc.
Consorteum Holdings Signs Mobile Application Development and Business Deal With Bet Butler Limited
Consorteum Holdings Inc. Announces ThreeFiftyNine's New Partner Program
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.4399, up 42.13%, on 10,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 4,113, and its 52-week low/high is $0.25/$0.89.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.
Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen Receives Notice of Allowance for U.S. Patent Expanding Stem Cell Technology Platform for Drug Rescue and Regenerative Medicine
VistaGen Joins the Cardiac Safety Research Consortium
VistaGen Provides Update on $36 Million Strategic Financing Agreement
Armco Metals Holdings, Inc. (AMCO)
The QualityStocks Daily Newsletter would like to spotlight Armco Metals Holdings, Inc. (AMCO). Today, Armco Metals Holdings, Inc. closed trading at $0.3298, up 9.93%, on 160,776 volume with 269 trades. The stock’s average daily volume over the past 60 days is 545,845, and its 52-week low/high is $0.18/$0.58.
Armco Metals Holdings, Inc. (AMCO), since its founding 10 years ago, has worked tirelessly to create low-cost, high-quality solutions to meet steel industry demands and achieve its goal to become the largest scrap steel recycler in China. The company operates through five subsidiaries located in key regions throughout the country to source, import, process, and distribute quality, environmentally friendly recycled scrap steel, as well as metal and non-ferrous metal ore.
Subsidiaries Armco Metals International, Ltd., Armco (Lianyungang) Renewable Metals, Inc., Armet (Lianyungang) Holdings, Inc., Henan Armco & Metawise Trading Co., Ltd., Armco Metals (Shanghai) Holding, Ltd. support Armco Metal’s overarching corporate mission and operate to provide the country’s steel production industry with sustainable, responsible solutions to its material needs. Aligned with China’s green initiatives, Armco Metals and its subsidiaries are helping the government reach its scrap metal consumption goal of 20% by 2015.
Leveraging long-standing relationships with more than 10 international metal suppliers, more than 100 small- and medium-sized Chinese steel production companies, and some of the country’s large state-run foundries, Armco Metals benefits from a steady and dependable supply of demand for the company’s high-quality product known for excellent market values.
Armco Metals’ management team has established a unique approach to business and environment by providing responsible solutions based on environmentally friendly practices; reliable, cost-effective sourcing; and quality metal products. Backed by more than 10 years of industry experience, company executives have successfully positioned the company as credible, dependable partner for customers, suppliers, and investors within the steel production market. Disclaimer
Armco Metals Holdings, Inc. Company Blog
Armco Metals Holdings, Inc. News:
Armco Metals Holdings Enters Into Agreement to Acquire 100% of Draco Resources, Inc.
Armco Metals Holdings Announces Financial Results for the Fourth Quarter and Full Year of 2013
Armco Metals Holdings, Inc. and Midland Resources Enter Into Steel Scrap Supply Agreement
Global Payout, Inc. (GOHE)
The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.15, up 7.14%, on 50,500 volume with 8 trades. The stock’s average daily volume over the past 60 days is 60,130, and its 52-week low/high is $0.03/$0.41.
Global Payout, Inc. (GOHE) specializes in customized payment solutions for businesses and organizations worldwide. The company’s global network of banks and processing partners enable companies and organizations to efficiently deploy a customized payment solution configured specifically for each client. From solving a single payment issue to meeting an entire global payment requirement, Global Payout in conjunction with its partners delivers modular payment solutions.
Global Payout has a product line of prepaid "off the shelf" products that can be utilized or Global Payout can customize payment solutions for qualified businesses. By coupling its network of international banks and third-party processing relationships with an innovative payment platform, Global Payout enables organizations to "plug into" an efficient and cost effective method of paying employees, contractors, investors, and commissioned agents wherever they might be located in the world.
Global Payout began operations as a business to business provider of pre-paid debit cards for payroll and general spend programs. The company then launched a Prepaid Discover® card to meet the demand of its business clients in the United States. As a result of these efforts and with the input of their client base, Global Payout then greatly extended its reach by developing a new proprietary “payment platform” which enables companies and organizations to make necessary payments in every country a company does business. Clients can now make international payments without the need to establish banking relationships in each and every country they do business. Businesses now have an efficient, compliant and simplified system to make their all necessary international payments using Global Payout’s proprietary payment platform.
Global Payout delivers dependable and secure global payment solutions for companies worldwide. This relieves clients of burdensome and time consuming efforts to establish banking relationships everywhere they do business. The company’s “consolidated payment gateway” product can be configured specifically to the needs of each client within a short period of time. Global Payout is led by a management team comprised of pioneers in domestic and international payment delivery solutions. The company is well positioned to leverage their long standing international financial relationships to expand their services and global reach. Even during this expansion, Global Payout remains committed to serving domestic and international clients and providing them with customized one-stop solutions that address each client’s specific payment needs. Disclaimer
Global Payout, Inc. Company Blog
Global Payout, Inc. News:
Security Enhancement Moves by Target Corp. to Include Chip and PIN Technology Lauded by Global Payout
Global Payout's Financial Services Platform Extends Direct Access To Bank Networks in the Philippines
Fraud Prevention, Regulatory Compliance and Risk Mitigation Provided Through Global Financial Services Company
Today's Top 3
Pumps and Dumps
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Armco Metals Holdings, Inc. (AMCO) Enters Into Agreement to Acquire 100% of Draco Resources, Inc.
- Colt Resources Inc. (COLTF) provides Operational Update on Portuguese projects
- Consorteum Holdings, Inc. (CSRH) Enters Mobile Application Development and Business Agreement With XpertX, Inc.
- eCrypt Technologies, Inc. (ECRY) Appoints Former Microsoft Engineer to Advisory Board
- Global Payout, Inc. (GOHE) Security Enhancement Moves by Target Corp. to Include Chip and PIN Technology Lauded by Global Payout
- Great Plains Holdings, Inc. (GTPH) Completes Final Phase of Real Estate Asset Project Ahead of Schedule
- Infinite Group, Inc. (IMCI) Cybersecurity In Focus At IMCI With New Hire
- Innocent, Inc. (INCT) Announces Letter to Shareholders
- International Stem Cell Corp. (ISCO) Announces Positive Parkinson's Disease Data
- Kallo, Inc. (KALO) Announces Appointment of Two Senior Managers
- Mabwe Minerals Inc. (MBMI) Raptor Resources Holdings Issues Update on the Derbyshire Stone Quarry
- NeuroMama, Ltd. (NERO) CES Event Showcasing Intelligent Search Engine, Online Retail Platform and Advertising Opportunities, Reception Act Performer Fall and Serious Injuries Documented
- NutraNomics, Inc. (NNRX) Discusses Long-Term Global Expansion Strategy with UNO International Corp.
- P2 Solar, Inc. (PTOS) Signs Implementation Agreement for Rajgarh Hydro Project
- Pan Global Corp. (PGLO) Announces Positive Initial Site Visits to and Inspections of First Small-Hydro Plant Project in Northern India
- Raptor Resources Holdings Inc. (RRHI) Issues Update on the Derbyshire Stone Quarry
- Start Scientific, Inc. (STSC) is “One to Watch”
- Victory Energy Corp. (VYEY) Successfully Completes Fourth Well in Its Permian Lightnin Prospect
- VistaGen Therapeutics, Inc. (VSTA) Receives Notice of Allowance for U.S. Patent Expanding Stem Cell Technology Platform for Drug Rescue and Regenerative Medicine
- Well Power Inc. (WPWR) Conducts Successful Live Webinar with Strong Industry Participation
- Zenosense, Inc. (ZENO) Enters Into $475,000 Securities Purchase Agreement